mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.35 |
0.2 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |